Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.
The Global Assisted Reproductive Technology (ART) Market size was USD 23.56 billion in 2020 and is projected to reach USD 47.12 billion by 2028, at a compound annual growth rate (CAGR) of 9.8% during the forecast period, 2021-2028.
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization, and various technological and procedure up gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs of poor quality. In February 2015, the scientist of U.S. who invented the three-parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.
This report focuses on the global Assisted Reproductive Technology (ART) status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Assisted Reproductive Technology (ART) development in United States, Europe, and China.
The study objectives of this report are:
In this study, the years considered to estimate the market size of Assisted Reproductive Technology (ART) are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2028
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Assisted Reproductive Technology (ART) Market Size Growth Rate by Type (2017-2028)
1.4.2 Fresh Donor
1.4.3 Fresh Nondonor
1.4.4 Frozen Donor
1.4.5 Frozen Nondonor
1.4.6 Egg/Embryo bank
1.5 Market by Application
1.5.1 Global Assisted Reproductive Technology (ART) Market Share by Application (2017-2028)
1.5.2 Women Younger Than Age 35
1.5.3 Women Older Than Age 35
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Assisted Reproductive Technology (ART) Market Size
2.2 Assisted Reproductive Technology (ART) Growth Trends by Regions
2.2.1 Assisted Reproductive Technology (ART) Market Size by Regions (2017-2028)
2.2.2 Assisted Reproductive Technology (ART) Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Assisted Reproductive Technology (ART) Market Size by Manufacturers
3.1.1 Global Assisted Reproductive Technology (ART) Revenue by Manufacturers (2017-2020)
3.1.2 Global Assisted Reproductive Technology (ART) Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Assisted Reproductive Technology (ART) Market Concentration Ratio (CR5 and HHI)
3.2 Assisted Reproductive Technology (ART) Key Players Head office and Area Served
3.3 Key Players Assisted Reproductive Technology (ART) Product/Solution/Service
3.4 Date of Enter into Assisted Reproductive Technology (ART) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Assisted Reproductive Technology (ART) Market Size by Type (2017-2020)
4.2 Global Assisted Reproductive Technology (ART) Market Size by Application (2017-2020)
5 United States
5.1 United States Assisted Reproductive Technology (ART) Market Size (2017-2020)
5.2 Assisted Reproductive Technology (ART) Key Players in United States
5.3 United States Assisted Reproductive Technology (ART) Market Size by Type
5.4 United States Assisted Reproductive Technology (ART) Market Size by Application
6 Europe
6.1 Europe Assisted Reproductive Technology (ART) Market Size (2017-2020)
6.2 Assisted Reproductive Technology (ART) Key Players in Europe
6.3 Europe Assisted Reproductive Technology (ART) Market Size by Type
6.4 Europe Assisted Reproductive Technology (ART) Market Size by Application
7 China
7.1 China Assisted Reproductive Technology (ART) Market Size (2017-2020)
7.2 Assisted Reproductive Technology (ART) Key Players in China
7.3 China Assisted Reproductive Technology (ART) Market Size by Type
7.4 China Assisted Reproductive Technology (ART) Market Size by Application
8 Japan
8.1 Japan Assisted Reproductive Technology (ART) Market Size (2017-2020)
8.2 Assisted Reproductive Technology (ART) Key Players in Japan
8.3 Japan Assisted Reproductive Technology (ART) Market Size by Type
8.4 Japan Assisted Reproductive Technology (ART) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Assisted Reproductive Technology (ART) Market Size (2017-2020)
9.2 Assisted Reproductive Technology (ART) Key Players in Southeast Asia
9.3 Southeast Asia Assisted Reproductive Technology (ART) Market Size by Type
9.4 Southeast Asia Assisted Reproductive Technology (ART) Market Size by Application
10 India
10.1 India Assisted Reproductive Technology (ART) Market Size (2017-2020)
10.2 Assisted Reproductive Technology (ART) Key Players in India
10.3 India Assisted Reproductive Technology (ART) Market Size by Type
10.4 India Assisted Reproductive Technology (ART) Market Size by Application
11 Central & South America
11.1 Central & South America Assisted Reproductive Technology (ART) Market Size (2017-2020)
11.2 Assisted Reproductive Technology (ART) Key Players in Central & South America
11.3 Central & South America Assisted Reproductive Technology (ART) Market Size by Type
11.4 Central & South America Assisted Reproductive Technology (ART) Market Size by Application
12 International Players Profiles
12.1 Irvine Scientific
12.1.1 Irvine Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Assisted Reproductive Technology (ART) Introduction
12.1.4 Irvine Scientific Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.1.5 Irvine Scientific Recent Development
12.2 Origio a/s
12.2.1 Origio a/s Company Details
12.2.2 Company Description and Business Overview
12.2.3 Assisted Reproductive Technology (ART) Introduction
12.2.4 Origio a/s Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.2.5 Origio a/s Recent Development
12.3 Vitro Life
12.3.1 Vitro Life Company Details
12.3.2 Company Description and Business Overview
12.3.3 Assisted Reproductive Technology (ART) Introduction
12.3.4 Vitro Life Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.3.5 Vitro Life Recent Development
12.4 Esco Micro Pte. Ltd.
12.4.1 Esco Micro Pte. Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Assisted Reproductive Technology (ART) Introduction
12.4.4 Esco Micro Pte. Ltd. Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.4.5 Esco Micro Pte. Ltd. Recent Development
12.5 IVFtech ApS
12.5.1 IVFtech ApS Company Details
12.5.2 Company Description and Business Overview
12.5.3 Assisted Reproductive Technology (ART) Introduction
12.5.4 IVFtech ApS Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.5.5 IVFtech ApS Recent Development
12.6 Research Instruments
12.6.1 Research Instruments Company Details
12.6.2 Company Description and Business Overview
12.6.3 Assisted Reproductive Technology (ART) Introduction
12.6.4 Research Instruments Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.6.5 Research Instruments Recent Development
12.7 Genea Limited
12.7.1 Genea Limited Company Details
12.7.2 Company Description and Business Overview
12.7.3 Assisted Reproductive Technology (ART) Introduction
12.7.4 Genea Limited Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.7.5 Genea Limited Recent Development
12.8 Smiths Medical
12.8.1 Smiths Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Assisted Reproductive Technology (ART) Introduction
12.8.4 Smiths Medical Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.8.5 Smiths Medical Recent Development
12.9 Thermo Fisher Scientific, Inc.
12.9.1 Thermo Fisher Scientific, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Assisted Reproductive Technology (ART) Introduction
12.9.4 Thermo Fisher Scientific, Inc. Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.9.5 Thermo Fisher Scientific, Inc. Recent Development
12.10 Cook Medical
12.10.1 Cook Medical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Assisted Reproductive Technology (ART) Introduction
12.10.4 Cook Medical Revenue in Assisted Reproductive Technology (ART) Business (2017-2020)
12.10.5 Cook Medical Recent Development
13 Market Forecast 2021-2028
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2028)
13.10 Market Size Forecast by Application (2021-2028)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
